Webinars

On behalf of Myeloma Patients Europe, Prof. Dr. Hermann Einsele, shares his key myeloma highlights of the ASH 2025 conference.

Prof. Dr. Einsele is hematologist, oncologist, Professor of Internal Medicine and Director of the Department of Internal Medicine II at the University Hospital Würzburg in Germany. He is a world leading expert in the field of myeloma and immunotherapy and in particular CAR T-cells and bispecific antibodies.
His presentation featured outstanding clinical data from trials exploring bispecific antibody combinations (such as the MajesTEC-3 study), new medicines moving into earlier lines of therapy and novel CAR T-cell approaches that enable BCMA-directed CAR T-cells to be made directly inside the patient’s body (inMMyCAR study).
He emphasised that the myeloma treatment landscape has never evolved as rapidly as today and we thank him for his encouraging words and his professional and insightful presentation.

You can see more videos talking about some of the key myeloma data presented at ASH 2025 here https://www.mpeurope.org/ash-2025-myeloma-and-al-amyloidosis-updates/